Back to Search Start Over

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody.

Authors :
Choi BD
Gedeon PC
Sanchez-Perez L
Bigner DD
Sampson JH
Source :
Oncoimmunology [Oncoimmunology] 2013 Dec 01; Vol. 2 (12), pp. e26757. Date of Electronic Publication: 2013 Oct 22.
Publication Year :
2013

Abstract

Regulatory T cells (Tregs) play a central role in in tumor escape from immunosurveillance. We report that a bispecific T-cell engager (BiTE) targeting a mutated form of the epidermal growth factor receptor, i.e., EGFRvIII, potently redirects Tregs to kill glioblastoma through the granzyme-perforin pathway.

Details

Language :
English
ISSN :
2162-4011
Volume :
2
Issue :
12
Database :
MEDLINE
Journal :
Oncoimmunology
Publication Type :
Academic Journal
Accession number :
24475376
Full Text :
https://doi.org/10.4161/onci.26757